Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vella Bioscience
AddedFeb 16, 2024
UpdatedJun 18, 2026
Vella Bioscience

Vella Bioscience

Vella Bioscience, a health-tech firm, pioneers in female sexual empowerment with its unique, clinically-proven CBD lotion.

HQ
Worcester, MA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to sexually empower every woman, Vella Bioscience is a health-tech company that leverages scientific innovation to enhance female sexual wellness. Their flagship product, Vella, is a nano-encapsulated topical lotion designed to facilitate easier, more intense, and more frequent orgasms. This unique formulation, which includes cannabidiol (CBD), is clinically proven to relax vaginal smooth muscle, a key factor in sexual response. Vella Bioscience focuses on the female sexual health market, offering additional products like the Women’s Pleasure Serum and various lubricants.

Notable figures affiliated with Vella Bioscience include experts in sexual health and wellness, although specific names are not provided. The company has garnered attention for its groundbreaking approach and clinically-proven products, making significant strides in the realm of female sexual empowerment. Through its innovative offerings, Vella Bioscience has made a substantial impact on the sexual health industry, promoting the idea that sexual health is an essential component of overall well-being.

Vella Bioscience - Similar Companies

Inbold logo

Inbold

lassenlabs.com

V-Flow Medical logo

V-Flow Medical

Equilibria logo

Equilibria

myeq.com

Womaness logo

Womaness

womaness.com

House of Wise logo

House of Wise

houseofwise.co

Virtual Medical International logo

Virtual Medical International

Feals logo

Feals

feals.com

VelloHealth logo

VelloHealth

Root Bioscience logo

Root Bioscience

rootbioscience.com

Evofem Biosciences logo

Evofem Biosciences

evofem.com

Tabu logo

Tabu

heytabu.com

Out & About CBD logo

Out & About CBD

Verda Bio logo

Verda Bio

verdabio.com

Evvy logo

Evvy

evvy.com

Vitalibis logo

Vitalibis

Vella Bioscience - Quick Facts

Who are Vella Bioscience's competitors?

Companies similar to Vella Bioscience include Inbold, V-Flow Medical, Equilibria and Womaness.

When was Vella Bioscience founded?

Vella Bioscience was founded in 2020.

Where is Vella Bioscience's headquarters located?

Vella Bioscience's headquarters is located in Worcester, MA, US.

When was Vella Bioscience's last funding round?

Vella Bioscience's most recent funding round was for $7M (USD) in May 2021.

How much has Vella Bioscience raised to-date?

As of May 13, 2021, Vella Bioscience has raised a total of $8.6M (USD).

How many employees does Vella Bioscience have?

Vella Bioscience has 11 employees as of Feb 5, 2024.

Vella Bioscience - Classification

Industry
  • Retail
Ownership
  • Venture Capital
Technology
  • CBD
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Sexual Wellness
Tags
  • eCommerce
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified